
浏览全部资源
扫码关注微信
1.新乡市中心医院泌尿外科/新乡医学院第四临床学院,新乡 453000
2.郑州大学第一附属医院泌尿外科,郑州 450000
常海青,Email:haiqingkkk@163.com,研究方向:膀胱癌的基础及临床研究。
王 磊,Email:15637359566@163.com。
收稿:2023-06-12,
修回:2023-06-26,
录用:2023-07-20,
纸质出版:2023-08-28
移动端阅览
常海青,师磊,乔庆东,等.血清KLF5含量与阳性淋巴结比例的相关性及其对膀胱癌患者根治术后预后的预测价值[J].重庆医科大学学报,2023,48(8):898-902.
Chang Haiqing,Shi Lei,Qiao Qingdong,et al.Correlation between serum KLF5 content and positive lymph node ratio and its predictive value for prognosis of patients with bladder cancer after radical operation[J].Journal of Chongqing Medical University,2023,48(8):898-902.
常海青,师磊,乔庆东,等.血清KLF5含量与阳性淋巴结比例的相关性及其对膀胱癌患者根治术后预后的预测价值[J].重庆医科大学学报,2023,48(8):898-902. DOI: 10.13406/j.cnki.cyxb.003311.
Chang Haiqing,Shi Lei,Qiao Qingdong,et al.Correlation between serum KLF5 content and positive lymph node ratio and its predictive value for prognosis of patients with bladder cancer after radical operation[J].Journal of Chongqing Medical University,2023,48(8):898-902. DOI: 10.13406/j.cnki.cyxb.003311.
目的
2
探究血清Kruppel样因子5(recombinant Kruppel factor 5,KLF5)含量与阳性淋巴结比例的相关性及其对膀胱癌患者根治术后预后的预测价值。
方法
2
选取新乡市中心医院和郑州大学第一附属医院泌尿外科2019年6月至2022年9月进行根治性膀胱切除术治疗的92例膀胱癌患者作为研究对象,根据疗效分为有效组和无效组。酶联免疫吸附法检测血清KLF5的表达水平、分析血清KLF5含量与阳性淋巴结比例的相关性和预后的预测价值分析。
结果
2
治疗有效组患者血清KLF5的表达水平显著低于无效组(
P
<
0.05);有效组患者阳性淋巴结比例与无效组相比,具有显著差异(
P
<
0.05);采用Pearson分析血清KLF5与阳性淋巴结比例间关系,发现血清KLF5与阳性淋巴结比例呈正相关(
r
=0.607);logistic多因素回归分析显示,血清KLF5(
OR
=2.751,
95%
CI=1.777~4.260,
P
=0.000)与阳性淋巴结比例(
OR
=2.751,95
%
CI=1.389~7.342,
P
=0.006)是影响膀胱癌根治术患者病情预后的独立危险因素;ROC结果显示,血清KLF5与阳性淋巴结比例对预测膀胱癌根治术患者预后的曲线下面积(area under the curve,AUC)分别为0.909、0.748,对应灵敏度分别为80.71%、93.26%,特异度分别为91.24%、92.50%。二者联合诊断的AUC为0.929,灵敏度和特异度分别为92.30%和92.50%。
结论
2
血清KLF5和阳性淋巴结比例是膀胱根治术患者预后的独立危险因素,并且KLF5与患者的阳性淋巴结比例呈正相关,因此在预测膀胱根治术患者预后的过程中,动态检测相关影响因素的变化可以为临床医生诊断病情提供依据。
Objective
2
To explore the correlation between serum recombinant Kruppel factor 5(KLF5) content and positive lymph node ratio and its predictive value for the prognosis of patients with bladder cancer after radical operation.
Methods
2
Ninety-two patients in Department of Urinary Surgery,Xinxiang Central Hospital and The First Affiliated Hospital of Zhengzhou University with bladder cancer treated by radical cystectomy from June 2019 to September 2022 were selected for the study,and they were divided into effective and ineffective groups according to their efficacy. The expression level of serum KLF5 was obtained by enzyme-linked immunosorbent assay. The correlation between serum KLF5 content and positive lymph node ratio and its predictive value for prognosis were analyzed.
Results
2
The expression level of serum KLF5 in patients in the effective group was significantly lower than that in the ineffective group(
P
<
0.05); the positive lymph node ratio in patients in the effective group was significantly different compared with that in the ineffective group(
P
<
0.05). Pearson analysis showed that a positive correlation was found between serum KLF5 and positive lymph node ratio(odds ratio=0.607;
P
=0.000). Multivariate logistic regression analysis showed that serum KLF5(
OR
=2.751,95
%
CI=1.777-4.260,
P
=0.000) and positive lymph node ratio(
OR
=2.751,95
%
CI=1.389-7.342,
P
=0.006) were independent risk factors affecting the prognosis of patients undergoing radical cystectomy(
P
<
0.05). The receiver operating characteristic curve results showed that the areas under the curve(AUCs) of serum KLF5 and positive lymph node ratio were 0.909 and 0.748,respectively,for predicting the prognosis of patients undergoing radical cystectomy. The corresponding sensitivity was 80.71% and 93.26%,and the specificity was 91.24% and 92.50%,respectively. The AUC for the combined diagnosis of the two indicators was 0.929,with a sensitivity and specificity of 92.30% and 92.50%,respectively.
Conclusion
2
Serum KLF5 and positive lymph node ratio are independent risk factors for the prognosis of patients undergoing radical cystectomy,and KLF5 is positively correlated with positive lymph node ratio in patients undergoing radical cystectomy. Therefore,in the process of predicting the prognosis of patients undergoing radical cystectomy,dynamic detection of changes in related influencing factors can provide a basis for clinicians to diagnose the disease.
李辉章 , 郑荣寿 , 杜灵彬 , 等 . 中国膀胱癌流行现状与趋势分析 [J ] . 中华肿瘤杂志 , 2021 , 43 ( 3 ): 293 - 298 .
Li HZ , Zheng RS , Du LB , et al . Epidemic status and trend analysis of bladder cancer in China [J ] . Chinese Journal of Cancer , 2021 , 43 ( 3 ): 293 - 298 .
Witjes JA , Bruins HM , Cathomas R , et al . European Association of Urology Guidelines on muscle-invasive and metastatic bladder cancer:summary of the 2020 guidelines [J ] . Eur Urol . 2021 , 79 ( 1 ): 82 - 104 .
赵佳琳 , 林燕 , 王常珺 , 等 . 临床腋窝淋巴结阳性老年三阴性乳腺癌局部治疗策略 [J ] . 协和医学杂志 , 2019 , 10 ( 3 ): 293 - 298 .
Zhao JL , Lin Y , Wang CJ , et al . Local treatment strategy for triple negative breast cancer in elderly patients with positive axillary lymph nodes [J ] . Peking Union Medical Journal , 2019 , 10 ( 3 ): 293 - 298 .
孔令伟 , 吕宪宝 . miR-145靶向KLF5抑制膀胱癌BIU-87细胞增殖、侵袭、迁移的机制研究 [J ] . 中国肿瘤外科杂志 , 2021 , 13 ( 1 ): 70 - 75,85 .
Kong LW , Lü XB . Study on the mechanism of targeting KLF5 to inhibit proliferation,invasion and migration of bladder cancer BIU-87 cells [J ] . Chinese Journal of Oncology Surgery , 2021 , 13 ( 1 ): 70 - 75,85 .
吴小飞 , 赛文莉 , 朱海燕 , 等 . 血清KLF5异常对良、恶性肝病诊断与鉴别诊断的临床价值 [J ] . 胃肠病学和肝病学杂志 , 2021 , 30 ( 9 ): 1044 - 1049 .
Wu XF , Sai WL , Zhu HY , et al . The clinical value of abnormal serum KLF5 in the diagnosis and differential diagnosis of benign and malignant liver diseases [J ] Journal of Gastroenterology and Hepatology , 2021 , 30 ( 9 ): 1044 - 1049 .
刘秋华 , 林榕波 . 实体瘤疗效评价标准(RECIST)指南1.1版 [C ] // 第十二届全国临床肿瘤大会暨2009年CSCO学术年会 , 2009 .
Liu QH , Lin RB . Guidelines for the Evaluation of Solid Tumor Efficacy(RECIST),Version 1.1 [C ] // The 12th National Clinical Oncology Conference and 2009 CSCO Academic Annual , 2009 .
黄燊香 , 刘秋梅 , 林银霞 , 等 . 膀胱癌患者术后复发相关影响因素分析 [J ] . 广西医科大学学报 , 2022 , 39 ( 6 ): 918 - 922 .
Huang SX , Liu QM , Lin YX , et al . Analysis of related factors of postoperative recurrence of bladder cancer [J ] . Journal of Guangxi Medical University , 2022 , 39 ( 6 ): 918 - 922 .
Cai Q , Chen Y , Xin S , et al . Temporal trends of bladder cancer incidence and mortality from 1990 to 2016 and projections to 2030 [J ] . Transl Androl Urol , 2020 , 9 ( 2 ): 153 - 165 .
董文 . 肌层浸润性膀胱癌新辅助与辅助免疫治疗的现状与展望 [J ] . 中华腔镜泌尿外科杂志 (电子版), 2023 , 17 ( 1 ): 1 - 6 .
Dong W . Status and prospect of new adjuvant and adjuvant immunotherapy for myometrial invasive bladder cancer [J ] . Chinese Journal of Endoscopic Urology(Electronic Edition) , 2023 , 17 ( 1 ): 1 - 6 .
韦飞 , 王晶运 , 王帅 , 等 . 机器人辅助腹腔镜下膀胱癌根治术中先后行标准淋巴结清扫的近期疗效对比 [J ] . 现代泌尿生殖肿瘤杂志 , 2022 , 14 ( 2 ): 82 - 86 .
Wei F , Wang JY , Wang S , et al . Comparison of short-term efficacy of standard lymph node dissection in robot assisted laparoscopic radical surgery for bladder cancer [J ] . Modern Journal of Urogenital neoplasm , 2022 , 14 ( 2 ): 82 - 86 .
陈俊任 , 杨定华 , 孙艳花 , 等 . TAZ和KLF5在肝细胞癌组织中的表达及其临床意义 [J ] . 中国免疫学杂志 , 2015 , 31 ( 3 ): 380 - 383 .
Chen JR , Yang DH , Sun YH , et al . The expression and clinical significance of TAZ and KLF5 in hepatocellular carcinoma tissue [J ] . Chinese Journal of Immunology , 2015 , 31 ( 3 ): 380 - 383 .
蔡建珊 , 殷保兵 . 阳性淋巴结个数和比例与胆囊癌预后的相关因素分析 [C ] // 2019中国肿瘤学大会论文集 , 2019 : 3948 - 3948 .
Cai JS , Yin BB . Analysis of the correlation factors between the number and proportion of positive lymph nodes and the prognosis of gallbladder cancer [C ] // Proceedings of the 2019 China Oncology Conference , 2019 : 3948 - 3948 .
王书华 , 陈旭升 , 张振庭 , 等 . 盆腔淋巴结清扫对评估膀胱癌预后的价值 [J ] . 中国肿瘤临床 , 2015 , 42 ( 17 ): 866 - 870 .
Wang SH , Chen XS , Zhang ZT , et al . The value of pelvic lymph node dissection in evaluating the prognosis of bladder cancer [J ] . Chinese Journal of Oncology , 2015 , 42 ( 17 ): 866 - 870 .
武程 , 张鹏 , 倪浩东 , 等 . 血清可溶性Fas评判浅表性膀胱癌复发的意义 [J ] . 东南大学学报(医学版) , 2015 , 34 ( 2 ): 231 - 234 .
Wu C , Zhang P , Ni HD , et al . The significance of serum soluble Fas in evaluating the recurrence of superficial bladder cancer [J ] . Journal of Southeast University(Medical Edition) , 2015 , 34 ( 2 ): 231 - 234 .
Jiang ZJ , Zhang YD , Cao RF , et al . miR-5195-3p inhibits proliferation and invasion of human bladder cancer cells by directly targeting oncogene KLF5 [J ] . Oncology Research , 2017 , 25 ( 7 ): 1081 - 1087 .
Du C , Gao Y , Xu S , et al . KLF5 promotes cell migration by up-regulating FYN in bladder cancer cells [J ] . FEBS letters , 2016 , 590 ( 3 ): 408 - 418 .
Gao Y , Wu KJ , Chen YL , et al . Beyond proliferation:KLF5 promotes angiogenesis of bladder cancer through directly regulating VEGFA transcription [J ] . Oncotarget , 2015 , 6 ( 41 ): 43791 - 43805 .
张玉瑞 , 朱海鹏 , 王栋 , 等 . 人肌层浸润性膀胱癌组织及血清中circRHOT1表达及临床意义 [J ] . 临床肿瘤学杂志 , 2022 , 27 ( 10 ): 903 - 909 .
Zhang YR , Zhu HP , Wang D , et al . Expression and clinical significance of circRHOT1 in human myometrial invasive bladder cancer tissue and serum [J ] . Journal of Clinical Oncology , 2022 , 27 ( 10 ): 903 - 909 .
石小玲 , 顾叶飞 , 蔡芸 . 膀胱癌组织和血清miR-200b甲基化状态与EMT及临床病理特征的相关性研究 [J ] . 东南大学学报(医学版) , 2022 , 41 ( 1 ): 95 - 101 .
Shi XL , Gu YF , Cai Y . Study on the correlation of miR-200b methylation status in bladder cancer tissue and serum with EMT and clinicopathological characteristics [J ] . Journal of Southeast University(Medical Edition) , 2022 , 41 ( 1 ): 95 - 101 .
董友志 , 廖 勇 . KLF5对吉西他滨诱导的肺腺癌细胞凋亡的促进作用及其机制 [J ] . 四川大学学报(医学版) , 2015 , 46 ( 1 ): 35 - 41 .
Dong YZ , Liao Y . Promotive effect and its molecular mechanism of KLF5 on gemcitabine-induced apoptosis in human lung adenocarcinoma cell line H441 [J ] . J Sichuan Univ Med Sci Ed , 2015 , 46 ( 1 ): 35 - 41 .
Wei R , Zhou Y , Li C , et al . Ketogenesis Attenuates KLF5-Dependent Production of CXCL12 to Overcome the Immunosuppressive Tumor Microenvironment in Colorectal Cancer [J ] . Cancer Res , 2022 , 82 ( 8 ): 1575 - 1588 .
李斌 , 李树斌 , 李俊杰 . 阳性淋巴结比率对胸腔镜下手术治疗食管癌患者生存状况的影响 [J ] . 医药论坛杂志 , 2021 , 42 ( 13 ): 39 - 43,47 .
Li B , Li SB , Li JJ . The effect of positive lymph node ratio on the survival status of patients with esophageal cancer undergoing Thoracoscopy surgery [J ] . Journal of Pharmaceutical Forum , 2021 , 42 ( 13 ): 39 - 43,47 .
0
浏览量
6
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621